Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy

As the coronavirus disease 2019 (COVID-19) pandemic is evolving, coagulopathy induced by the disease and its severe complications are raising concerns in the medical community. Because coagulopathy caused by COVID-19 has been difficult to control, it is important to have a better understanding of wh...

Descripción completa

Detalles Bibliográficos
Autor principal: Turshudzhyan, Alla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294862/
https://www.ncbi.nlm.nih.gov/pubmed/32550069
http://dx.doi.org/10.7759/cureus.8150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294862/
https://www.ncbi.nlm.nih.gov/pubmed/32550069
http://dx.doi.org/10.7759/cureus.8150

Ejemplares similares